148 related articles for article (PubMed ID: 15274203)
1. L-carnitine improves pH and decreases surface phosphatidylserine expression in extended stored apheresis platelets.
Sweeney JD; Kouttab NM; Arduini A
J Clin Apher; 2004; 19(2):98-102. PubMed ID: 15274203
[TBL] [Abstract][Full Text] [Related]
2. In vitro evaluation of COM.TEC apheresis platelet concentrates using a preparation set and pathogen inactivation over a storage period of five days.
Moog R; Fröhlich A; Mayaudon V; Lin L
J Clin Apher; 2004; 19(4):185-91. PubMed ID: 15597347
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo effects of potassium and magnesium on storage up to 7 days of apheresis platelet concentrates in platelet additive solution.
Diedrich B; Sandgren P; Jansson B; Gulliksson H; Svensson L; Shanwell A
Vox Sang; 2008 Feb; 94(2):96-102. PubMed ID: 18034788
[TBL] [Abstract][Full Text] [Related]
4. The quality of platelet concentrates produced by COBE Spectra and Trima Accel cell separators during storage for 7 days as assessed by in vitro methods.
Tynngård N; Lindahl TL; Trinks M; Studer M; Berlin G
Transfusion; 2008 Apr; 48(4):715-22. PubMed ID: 18208416
[TBL] [Abstract][Full Text] [Related]
5. Paired in vitro and in vivo comparison of apheresis platelet concentrates stored in platelet additive solution for 1 versus 7 days.
Shanwell A; Diedrich B; Falker C; Jansson B; Sandgren P; Sundkvist L; Svensson L; Vesterinen M; Gulliksson H
Transfusion; 2006 Jun; 46(6):973-9. PubMed ID: 16734814
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the in vitro properties of apheresis platelets during 7-day storage after interrupting agitation for one or three periods.
Wagner SJ; Vassallo R; Skripchenko A; Einarson M; Seetharaman S; Moroff G
Transfusion; 2008 Dec; 48(12):2492-500. PubMed ID: 18764829
[TBL] [Abstract][Full Text] [Related]
7. L-carnitine decreases glycolysis in liquid-stored platelets.
Sweeney JD; Blair AJ; Cheves TA; Dottori S; Arduini A
Transfusion; 2000 Nov; 40(11):1313-9. PubMed ID: 11099658
[TBL] [Abstract][Full Text] [Related]
8. Platelet function, activation and apoptosis during and after apheresis.
Bakry R; Sayed D; Galal H; Shaker S
Ther Apher Dial; 2010 Oct; 14(5):457-64. PubMed ID: 21175543
[TBL] [Abstract][Full Text] [Related]
9. Influence of apheresis container size on the maintenance of platelet in vitro storage properties after a 30-h interruption of agitation.
Wagner SJ; Skripchenko A; Seetharaman S; Myrup A; Kurtz J; Thomas-Montgomery D; Awatefe H; Moroff G
Transfus Apher Sci; 2010 Aug; 43(1):9-15. PubMed ID: 20554476
[TBL] [Abstract][Full Text] [Related]
10. Survival and recovery of apheresis platelets stored in a polyolefin container with high oxygen permeability.
Ezuki S; Kanno T; Ohto H; Herschel L; Ito T; Kawabata K; Seino O; Ikeda K; Nollet KE
Vox Sang; 2008 May; 94(4):292-8. PubMed ID: 18331381
[TBL] [Abstract][Full Text] [Related]
11. Storage of buffy-coat-derived platelets in additive solutions at 4 degrees C and 22 degrees C: flow cytometry analysis of platelet glycoprotein expression.
Sandgren P; Hansson M; Gulliksson H; Shanwell A
Vox Sang; 2007 Jul; 93(1):27-36. PubMed ID: 17547562
[TBL] [Abstract][Full Text] [Related]
12. In vitro evaluation of prestorage pooled leukoreduced whole blood-derived platelets stored for up to 7 days.
Heddle NM; Barty RL; Sigouin CS; Boye DM; Nelson EJ; Blajchman MA; Kelton JG
Transfusion; 2005 Jun; 45(6):904-10. PubMed ID: 15934988
[TBL] [Abstract][Full Text] [Related]
13. Improved extension of platelet storage in a polyolefin container with higher oxygen permeability.
Yuasa T; Ohto H; Yasunaga R; Kai T; Shirahama N; Ogata T
Br J Haematol; 2004 Jul; 126(1):153-9. PubMed ID: 15198746
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of in vitro storage properties of prestorage pooled whole blood-derived platelets suspended in 100 percent plasma and treated with amotosalen and long-wavelength ultraviolet light.
Wagner SJ; Skripchenko A; Myrup A; Awatefe H; Thompson-Montgomery D; Moroff G; Carmichael P; Lin L
Transfusion; 2009 Apr; 49(4):704-10. PubMed ID: 19171001
[TBL] [Abstract][Full Text] [Related]
15. Maintenance of in vitro properties of leukoreduced whole blood-derived pooled platelets after a 24-hour interruption of agitation.
Vassallo RR; Wagner SJ; Einarson M; Nixon J; Ziegler D; Moroff G
Transfusion; 2009 Oct; 49(10):2131-5. PubMed ID: 19555418
[TBL] [Abstract][Full Text] [Related]
16. The effect of gamma irradiation on the quality of apheresis platelets during storage for 7 days.
Tynngård N; Studer M; Lindahl TL; Trinks M; Berlin G
Transfusion; 2008 Aug; 48(8):1669-75. PubMed ID: 18482187
[TBL] [Abstract][Full Text] [Related]
17. Impact of different hold time before addition of platelet additive solution on the in vitro quality of apheresis platelets.
Ringwald J; Haager B; Krex D; Zimmermann R; Strasser E; Antoon M; De Schrijver E; Eckstein R
Transfusion; 2006 Jun; 46(6):942-8. PubMed ID: 16734810
[TBL] [Abstract][Full Text] [Related]
18. Pathogen reduction of buffy coat platelet concentrates using riboflavin and light: comparisons with pathogen-reduction technology-treated apheresis platelet products.
Li J; de Korte D; Woolum MD; Ruane PH; Keil SD; Lockerbie O; McLean R; Goodrich RP
Vox Sang; 2004 Aug; 87(2):82-90. PubMed ID: 15355498
[TBL] [Abstract][Full Text] [Related]
19. Quality of platelet concentrates derived by platelet rich plasma, buffy coat and Apheresis.
Vasconcelos E; Figueiredo AC; Seghatchian J
Transfus Apher Sci; 2003 Aug; 29(1):13-6. PubMed ID: 12877887
[TBL] [Abstract][Full Text] [Related]
20. Effects of Mirasol PRT treatment on storage lesion development in plasma-stored apheresis-derived platelets compared to untreated and irradiated units.
Picker SM; Steisel A; Gathof BS
Transfusion; 2008 Aug; 48(8):1685-92. PubMed ID: 18513255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
